The global BCG vaccine market size is expected to reach USD 73.02 Million in 2028 at a CAGR of 4.5% during the forecast period, according to the latest report by Reports and Data. Increasing focus on BCG revaccination approach, growing demand for BCG vaccine to combat rising prevalence of tuberculosis, rising emphasis on immunization in emerging economies, and technological advancements in vaccine and drug development processes are key factors expected to drive market revenue growth over the forecast period. In addition, BCG vaccine is an integral part of the national childhood immunization programs in several countries and is also used to treat bladder cancer. These are some other key factors driving demand for BCG vaccine and are expected to fuel revenue growth of the market going ahead.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/266
BCG vaccine is parenterally administered to infants across the globe, majorly in countries with high prevalence of tuberculosis, as a part of the Expanded Program on Immunization by the World Health Organization. In addition, BCG vaccine has several beneficial off-target effects on immune system that confer protection against a broad spectrum of other infections such as chest infections and diarrhea, among others, and this is another key factor expected to fuel demand for BCG vaccine and drive market growth over the forecast period. However, global shortage of BCG vaccine, manufacturing and supply chain problems, and ineffectiveness of BCG vaccine in controlling the tuberculosis epidemic are some key factors expected to restrain market growth to a certain extent over the forecast period.
Some Key Highlights from the Report:
- Immune BCG vaccine segment is expected to account for largest revenue share over the forecast period, attributable to increasing administration of BCG vaccine in neonates and young children to provide protection against childhood tuberculosis meningitis. Administration of BCG vaccine as a part of immunization protocol has resulted in 50% reduction in childhood mortality and offers protection against multiple pathogens.
- Pediatric segment is expected to register robust revenue CAGR over the forecast period owing to a sharp increase in birth rates across the globe, growing focus on development of robust TB control programs, rising demand for BCG vaccine to prevent childhood tuberculosis, and emphasis on mandatory vaccination of neonates and young children.
- Hospital segment is expected to register significant revenue growth over the forecast period, attributed to increasing availability of vaccine in hospital settings, immunization of new born babies, favorable reimbursement policies, availability of skilled professionals and advanced healthcare facilities, and implementation of TB control strategies in hospital settings.
- North America is expected to register considerable revenue growth over the forecast period owing to rising focus on immunization of children and new born babies in the United States, availability of cost-effective vaccine, and increasing initiatives to promote vaccination in the region.
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, and product & service portfolio. The Dry Mouth Relief market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.
Leading companies operating in the market are:
- Merck & Co., Inc.
- Sanofi Pasteur
- Japan BCG Laboratory
- China National Biotec Group
- Serum Institute of India Pvt. Ltd.
- InterVax Ltd.
- GreenSignal Bio Pharma Limited (GSBPL)
- Statens Serum Institut.
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/266
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
Dry Mouth Relief Market Segmentation:
Type Outlook:
- Immune BCG
- Therapy BCG
Application Outlook:
- Pediatric
- Adult
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)
Some essential purposes of the Dry Mouth Relief market research report:
- Vital Developments: Custom investigation provides critical improvements to the Dry Mouth Relief market, including R&D, new item shipment, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working in the market on a global scale and regional.
- Market Characteristics: The report contains Dry Mouth Relief market highlights, income, limit, limit utilization rate, value, net, creation rate, generation, utilization, import, trade, supply, demand, cost, part of the industry in general, CAGR, and gross margin. Likewise, the market report offers an exhaustive investigation of the elements and their most recent patterns, along with Service market fragments and subsections.
- Investigative Tools: This market report incorporates the accurately considered and evaluated information of the major established players and their extension into the Dry Mouth Relief market by methods. Systematic tools and methodologies, for example, Porter’s Five Powers Investigation, Possibilities Study, and numerous other statistical investigation methods have been used to analyze the development of the key players working in the Dry Mouth Relief market.
- Convincingly, the Dry Mouth Relief report will give you an unmistakable perspective on every single market reality without the need to allude to some other research report or source of information. This report will provide all of you with the realities about the past, present, and eventual fate of the Dry Mouth Relief market.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/266
Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Explore More Industry Research by Reports and Data:
Paraganglioma Market @ https://www.biospace.com/article/paraganglioma-market-deamd-2022-2030-rise-in-unhealthy-habits-such-as-excessive-alcohol-consumption-is-factor-ot-drive-industry-growth/
Opioid Overdose Market @ https://www.biospace.com/article/opioid-overdose-market-demand-2022-2030-increased-use-of-synthetic-opioids-such-as-fentanyl-a-powerful-synthetic-opioid-is-factor-to-driver-growth-of-industry/
Eosinophilic Asthma Market @ https://www.biospace.com/article/eosinophilic-asthma-market-to-register-a-healthy-y-o-y-growth-rate-through-2030/
Dravet Syndrome Market @ https://www.biospace.com/article/dravet-syndrome-market-to-grow-substantially-through-2030/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos